Polyclonal human antibodies reduce bacterial attachment to soft contact lens and corneal cell surfaces.
Bacterial keratitis due to Pseudomonas aeruginosa is a potentially serious complication of extended-wear contact lens use. Adhesion of P. aeruginosa to soft contact lens materials or corneal endothelial cells in the presence of pooled human immunoglobulins and/or neutrophils in artificial tear fluid was studied in vitro as a potential method to treat contact lens-associated infection. Soft hydrophilic contact lens materials equilibrated in sterile saline were soaked in artificial tear fluid for 18 h prior to use. P. aeruginosa IFO 3455 was added to groups of lenses or confluent cultured bovine corneal endothelial cells with varying amounts of human polyclonal immunoglobulin (IgG) and human blood neutrophils or serum albumin as a control. After 2 or 4 h incubation, adherent viable bacteria on lenses were quantified. Fluorescence microscopy was used to assess bacterial adherence to bovine corneal endothelial cells in the presence and absence of IgG and neutrophils. Various concentrations of albumin had no effect on adhesion. Human immunoglobulin solutions (25 mg/ml) reduced P. aeruginosa adhesion by nearly 1 log and 2 logs after 2 and 4 h incubations, respectively. Neutrophils in combination with 25 mg/ml IgG reduced bacterial adhesion approximately 1 log over reduction in adhesion by neutrophils alone. Diluted human IgG (10 mg/ml) did not significantly decrease bacterial adhesion after 2 or 4 h, but did reduce adhesion in combination with human neutrophils at both time points. Similar reductions in amounts of fluorescently labeled bacteria adhered to cultured monolayers of corneal endothelial cells under these conditions were qualitatively observed.
D000418:Albumins / Q000494:pharmacology; D000818:Animals; D000906:Antibodies / Q000494:pharmacology*; D001422:Bacterial Adhesion; D002417:Cattle; D003261:Contact Lenses / Q000009:adverse effects*; D003315:Cornea / Q000166:cytology* / Q000382:microbiology*; D004727:Endothelium / Q000166:cytology; D006801:Humans; D007074:Immunoglobulin G / Q000378:metabolism; D007634:Keratitis / Q000382:microbiology* / Q000517:prevention & control*; D009504:Neutrophils / Q000378:metabolism / Q000382:microbiology; D009883:Ophthalmic Solutions / Q000494:pharmacology; D011550:Pseudomonas aeruginosa / Q000472:pathogenicity; D013997:Time Factors
D000418:Albumins; D000906:Antibodies; D007074:Immunoglobulin G; D009883:Ophthalmic Solutions